Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Soft Matter ; 16(9): 2266-2275, 2020 Mar 04.
Article in English | MEDLINE | ID: mdl-32039413

ABSTRACT

The encapsulation of small hydrophilic molecules and response to specific biological triggers in a controlled manner have become two of the significant challenges in biomedical research, in particular in the field of localized drug delivery and biosensing. This work reports the fabrication of free-standing microchamber array films made of biodegradable polymers for the encapsulation and enzymatically triggered release of small hydrophilic molecules. Polycaprolactone (PCL) microchamber arrays were demonstrated to fully biodegrade within 5 hours of exposure to lipase from Pseudomonas cepacia (lipase PS) at a concentration of 0.5 mg ml-1, with lower concentrations producing correspondingly longer degradation times. The gradual process of deterioration was real-time monitored utilising laser Fraunhofer diffraction patterns. Additionally, a small hydrophilic molecule, 5(6)-carboxyfluorescein (CF), was loaded into the PCL microchamber arrays in a dry state; however, the substantial permeability of the PCL film led to leakage of the dye molecules. Consequently, polylactic acid (PLA) was blended with PCL to reduce its permeability, enabling blended PCL-PLA (1 : 2 ratio correspondingly) microchamber arrays to trap the small hydrophilic molecule CF. PCL-PLA (1 : 2) microchamber arrays hold potential for controlled release under the catalysis of lipase within 26 hours. Additionally, it is calculated that approximately 11 pg of CF dye crystals was loaded into individual microchambers of 10 µm size, indicating that the microchamber array films could yield a highly efficient encapsulation.


Subject(s)
Bacterial Proteins/chemistry , Fluoresceins/chemistry , Lipase/chemistry , Polyesters/chemistry , Burkholderia cepacia/enzymology , Drug Compounding , Drug Delivery Systems/instrumentation , Hydrophobic and Hydrophilic Interactions
2.
Bratisl Lek Listy ; 120(5): 380-385, 2019.
Article in English | MEDLINE | ID: mdl-31113202

ABSTRACT

OBJECTIVES: The purpose of this study was to determine the effects of hypothermia and normothermia on the isolated human saphenous vein (SV) and internal mammary artery (IMA) responses to dexmedetomidine. METHODS: The response of human IMA and SV strips with (E+) and without (E-) endothelium subjected to cumulative concentrations of (10-9, 0-6 M) dexmedetomidine were recorded at 37 °C and at 28 °C. OnE-way ANOVA was used for analysis. A p < 0.05 was considered significant. RESULTS: At 37˚C dexmedetomidine resulted in similar significant concentration-dependent contractions in both E+ and E- SV strips (p < 0.05). At 37 °C dexmedetomidine resulted in significant concentration-dependent contractions in E+ IMA strips, these contractions were significantly lower at all concentrations of dexmedetomidine in E- compared to E+ IMA strips (p < 0.05). When results between similar groups of SV and IMA strips were compared, the contractions were significantly higher in the IMA strips in E+ and E- at 37 °C and also E- 28 °C groups compared to SV (p < 0.05). CONCLUSION: In conclusion, dexmedetomidine causes in vitro vasoconstriction in human IMA and SV grafts. These contractions are greater in IMA compared to SV grafts. Endothelium-derived pathways are possibly involved in the contractile responses of IMA. Moderate hypothermia augments vasoconstriction in SV grafts (Fig. 3, Ref. 27).


Subject(s)
Adrenergic alpha-2 Receptor Agonists , Dexmedetomidine , Hypothermia , Mammary Arteries , Saphenous Vein , Adrenergic alpha-2 Receptor Agonists/pharmacology , Dexmedetomidine/pharmacology , Humans , Mammary Arteries/diagnostic imaging , Saphenous Vein/transplantation , Vasoconstriction
3.
Bratisl Lek Listy ; 120(1): 40-45, 2019.
Article in English | MEDLINE | ID: mdl-30685991

ABSTRACT

OBJECTIVE: We aimed to investigate the vasoactive effects of dexmedetomidine on isolated human umbilical arteries and possible mechanisms involved. METHODS: Human umbilical artery strips were suspended in Krebs-Henseleit solution and dose-response curves were obtained for cumulative dexmedetomidine before and after incubation with different agents; propranolol, atropine, yohimbine, prazosin, indomethacin, verapamil. Effects of calcium on cumulative dexmedetomidine-induced contractions were also studied. RESULTS: Cumulative dexmedetomidine resulted in dose dependent contraction responses. Incubation with propranolol (Emax: 93.3 ± 3.26 %), atropine (Emax: 92.0 ± 6.54 %), or indomethacin (Emax: 94.25 ± 2.62 %), did not attenuate dexmedetomidine-elicited contractions (p > 0.05). There were significant decreases in the contraction responses of cumulative dexmedetomidine with yohimbine (Emax: 12.1 ± 11.9 %), prazosin (Emax: 28.8 ± 4.6 %) and verapamil (Emax: 11.2 ± 13.6 %) (p < 0.05). In Ca+2 free medium contraction responses to cumulative dexmedetomidine was insignificant (Emax: 5.20 ± 3.42 %). Addition of cumulative calcium to the Ca+2 free medium resulted in concentration dependent increase in contractions (Emax: 64.83 ± 37.7 %) (p < 0.05). CONCLUSION: Dexmedetomidine induces vasoconstriction in endothelial-free umbilical arteries via both, α1- and α2-adrenergic receptors and also extracellular Ca+2 concentrations play a major role. ß-adrenergic receptors, muscarinic cholinergic receptors, and inhibition of cyclooxygenase enzyme are not involved in this vasoconstriction (Fig. 3, Ref. 36).


Subject(s)
Analgesics, Non-Narcotic , Dexmedetomidine , Vasoconstriction , Analgesics, Non-Narcotic/pharmacology , Calcium , Dexmedetomidine/pharmacology , Humans , In Vitro Techniques , Muscle Contraction/drug effects , Muscle, Smooth, Vascular , Umbilical Arteries , Vasoconstriction/drug effects
4.
Z Gerontol Geriatr ; 46(8): 734-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23743880

ABSTRACT

The aim of this study is to bring into focus the living conditions of the older adults in Turkey by using quality of life (QoL) criteria through which to highlight dimensions relating to their QoL status in comparison to other age cohorts. Are there specific QoL issues among older adults that would indicate that they display systematic differences in comparison to other age cohorts in Turkey? To what extent are there gender differences among older adults in QoL status? Data from the EQLS conducted in 2007 provided the information for understanding the self-reported conditions of older adults. Analysis shows that, for historical and contemporary reasons, older adults in Turkey form a disadvantaged cohort compared to other groups. The level of deprivation among a large segment of older adults is noteworthy in terms of income, health, material living conditions and social relations. Moreover, current social policies are blind to the low level of welfare, cultural capital, and connectedness of older women, resulting in unacceptable levels of alienation, unhappiness, and marginal status.


Subject(s)
Aging/psychology , Geriatric Assessment/statistics & numerical data , Happiness , Health Status , Health Surveys , Quality of Life/psychology , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Middle Aged , Sex Distribution , Socioeconomic Factors , Turkey/epidemiology , Young Adult
5.
Br J Anaesth ; 100(1): 95-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17959585

ABSTRACT

BACKGROUND: Different methods and propofol formulations have been used to decrease propofol injection pain, but it remains an unresolved problem. We aimed to investigate the effect of i.v. acetaminophen pretreatment on the propofol injection pain. METHODS: One hundred and fifty ASA I-II patients undergoing general anaesthesia were randomly allocated into three groups. A 20-gauge catheter was inserted into a superficial radial vein of the left hand, and after the occlusion of venous drainage, Groups I, II, and III were pretreated with 40 mg of lidocaine in saline, 50 mg of i.v. acetaminophen, and 5 ml of saline, respectively. The occlusion was released after 2 min and one-fourth of the total propofol dose was injected into the vein over a period of 5 s. During the injection of both pretreatment solution and propofol, patients' pain was assessed and recorded as 0-3, corresponding to no, mild, moderate or severe pain, respectively. Chi2 and Kruskal-Wallis tests were used for the statistical analysis. For all analyses, differences were considered to be significant at P<0.05. RESULTS: Patient characteristics were similar among the groups. Incidence of pain on injection of propofol in control, i.v. acetaminophen, and lidocaine groups was 64%, 22% and 8%, respectively (P<0.05). CONCLUSIONS: Pretreatment with i.v. acetaminophen seems to be effective in attenuating pain during i.v. injection of propofol.


Subject(s)
Acetaminophen/therapeutic use , Anesthetics, Intravenous/adverse effects , Lidocaine/therapeutic use , Pain/prevention & control , Propofol/adverse effects , Adult , Analgesics, Non-Narcotic/therapeutic use , Anesthetics, Local/therapeutic use , Double-Blind Method , Female , Humans , Injections, Intravenous/adverse effects , Male , Middle Aged , Pain/etiology
6.
J Nutr Biochem ; 11(10): 509-14, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11120449

ABSTRACT

The present study was undertaken to evaluate the potential role of curcumin, the antioxidant principal from Curcuma longa Linn., and the sulphur-containing amino acid N-acetylcysteine against ethanol-induced changes in the levels of prostanoids. Biochemical assessment of liver damage was done by measuring the activities of serum enzymes (i.e., aspartate transaminase and alkaline phosphatase), which were significantly increased in rats fed ethanol, whereas the elevated levels of these enzymes were decreased after curcumin and N-acetylcysteine treatment to rats fed ethanol. We observed a significant increase in the levels of prostaglandins E(1), E(2), F(2alpha), and D(2) in liver, kidney, and brain. Administration of curcumin and N-acetylcysteine was shown to decrease the level of these prostanoids in the tissue studied.

7.
Indian J Exp Biol ; 38(1): 31-5, 2000 Jan.
Article in English | MEDLINE | ID: mdl-11233081

ABSTRACT

Carbohydrates are the integral parts of glyco-conjugates and play an important role in cellular functions. 2-Deoxy-D-glucose (2-dGlc) is a sugar analogue of glucose and mannose and is reported to inhibit the lipid-linked saccharide formation involved in N-linked glycosylation of proteins. Administration of 2-dGlc (1 mg/100 g body weight) produced a decrease in the tissue total glycosaminoglycans level. We found that the activity of the enzymes involved in the biosynthesis of precursors of glycosaminoglycans (GAG) decreased, but that of the degrading enzymes increased. Thus, the decreased levels of GAG in tissues in 2-dGlc-administered rats occurs via enhanced degradation as well as decreased synthesis.


Subject(s)
Arteriosclerosis/metabolism , Deoxyglucose/pharmacology , Glycosaminoglycans/metabolism , Hypercholesterolemia/metabolism , Protein Precursors/metabolism , Protein Processing, Post-Translational/drug effects , Animals , Arteriosclerosis/etiology , Arylsulfatases/metabolism , Cathepsin D/metabolism , Diet, Atherogenic , Glucuronidase/metabolism , Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)/metabolism , Glycosylation/drug effects , Hyaluronoglucosaminidase/metabolism , Hypercholesterolemia/complications , Male , Organ Specificity , Rats , Rats, Sprague-Dawley , Uridine Diphosphate Glucose Dehydrogenase/metabolism , beta-N-Acetylhexosaminidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...